Radial nerve palsy, with wrist drop and loss of finger and thumb extension, severely impairs grasp and release. In proximal or extensive defects, direct repair or grafting may fail, making distal nerve transfer a preferred alternative. Can distal median-to-radial nerve transfers restore hand extension and improve quality of life in patients with radial nerve injury? This prospective study included nine patients with radial nerve injuries treated using distal nerve transfer. Surgical reconstruction consisted of transfer of the median nerve branch to the flexor digitorum superficialis to the radial nerve branch for the extensor carpi radialis brevis, combined with transfer of the median nerve branch to the flexor carpi radialis to the posterior interosseous nerve. In addition, a pronator teres to extensor carpi radialis brevis tendon transfer was performed to facilitate wrist extension in long-standing lesions. Functional recovery of wrist, finger (II–V), and thumb extension was assessed 24 months postoperatively using a modified British Medical Research Council scale, and quality of life was evaluated preoperatively and at final follow-up using the PNSQoL questionnaire. All patients achieved satisfactory recovery (BMRC M3–M5) of wrist, finger, and thumb extension, with M4–M5 outcomes predominating, especially for wrist extension. Median PNSQoL improved from 49 to 78, with 88.9% reporting excellent quality of life. Distal median-to-radial nerve transfer reliably restores hand extension and improves patient-reported outcomes in proximal radial nerve injuries, though larger multicenter studies are needed for confirmation.
Ulnar nerve injuries lead to severe intrinsic hand muscle dysfunction and major impairment of grip, pinch, and quality of life. Distal nerve transfers have been introduced to overcome the limitations of conventional repair and grafting by shortening the regeneration distance and improving reinnervation of intrinsic muscles. Can distal anterior interosseous nerve to deep motor branch of the ulnar nerve (AIN-to-UN-DMB) transfer restore intrinsic hand function and improve patient-reported quality of life in proximal ulnar nerve injuries? Twelve patients with proximal ulnar nerve injuries underwent distal AIN-to-UN-DMB transfer and were prospectively evaluated at 24 months postoperatively. Outcomes included intrinsic muscle strength graded by the BMRC scale, Egawa's sign, dynamometric assessment of grasp and pinch strength, and quality of life measured using the PNSQoL questionnaire. At final follow-up, intrinsic muscle strength improved markedly: 27 muscles achieved M4 and 14 achieved M3 strength, compared with universal M0 preoperatively. Grasp strength increased from a mean of 42.3% to 82.5%, and pinch strength from 37.4% to 80.5% of the contralateral hand. Overall satisfactory functional recovery was achieved in 87.5% of patients. Mean PNSQoL score improved significantly from 47.7 preoperatively to 74.4 postoperatively (p < 0.001), with all patients reaching very good or excellent quality-of-life categories. Distal AIN-to-UN-DMB transfer enables meaningful restoration of intrinsic hand function, substantial gains in grasp and pinch strength, and significant improvement in quality of life, representing an effective reconstructive option for proximal ulnar nerve injuries.
Recurrence after surgical treatment remains a significant challenge in the management of chronic subdural hematoma (CSDH). Patients with large postoperative residual collections are at increased risk, and adjuvant dexamethasone treatment appears promising as it may reduce inflammation within residual collections. This study evaluates the effectiveness of adjuvant low-dose dexamethasone treatment in reducing recurrence rates in patients with significant residual hematomas (>50 %) after burr-hole drainage. A retrospective case-control study was conducted on CSDH patients treated at the Military Medical Academy, Belgrade, from 2016 to 2023. Patients undergoing burr-hole craniostomy with postoperative residual CSDH collection >50 % of the preoperative volume were included. A subset received adjuvant low-dose dexamethasone (initial 2 mg twice daily, tapering over three weeks) decided arbitrarily by the treating neurosurgeon. Primary outcome was recurrence. A total of 99 patients met the inclusion criteria, with a mean age of 74.1 years. Recurrence was observed in 16 of 70 patients (22.9 %) in the control compared to only 1 of 29 (3.4 %) in the dexamethasone group (OR = 0.12, p = 0.045). The protective effect remained pronounced in the multivariate model, and only a single mild dexamethasone adverse event was observed. Adjuvant low-dose dexamethasone significantly reduced recurrence rates in CSDH patients with large postoperative residual collections. These findings suggest that low-dose corticosteroid therapy may be a viable adjunct to surgical treatment, but only in cases at increased risk of recurrence. However, further prospective trials are necessary to confirm these results and establish standardized guidelines.